None of the genes mentioned in this paragraph, except TACC2 (3/1006 disruptive variants in CRC patients compared to 1/1609 in controls), showed an enrichment of germline disruptive and/or predicted pathogenic variants in cases compared to controls (Table S2) [28]. Here, TACC2 is linked to colorectal carcinoma.